Idebenone Catalog No.:M9526-2 14bS)-11-cyano-2

14bS)-11-cyano-2

3-dihydro-1H-inden-1-yl]oxy}-3-chlorobenzonitrile dihydrochloride

and AKT in MDA-MB-453 cells

InChi: InChI=1S/C5H15N2O3PS/c6-2-1-3-7-4-5-12-11(8

Nafamostat mesilate (1-10 mg/kg) produces the dose-dependent inhibition of scratching induced by intradermal compound 48/80 (10 mg/site)

Idebenone Catalog No.:M9526-2 14bS)-11-cyano-2Idebenone, also known as CV 2619, ss a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Product information CAS Number: 58186 27 9 Molecular Weight: 338. 44 Formula: C19H30O5